AIM ImmunoTech Long Term Deferred Charges (Quarterly) Insights

AIM ImmunoTech, Inc. (AIM)

1.29 -0.01 (-0.77%) USD | NYAM | Jan 07, 16:00

1.29 0.00 (0.00%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for AIM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Halozyme Therapeutics, Inc.	--
Perspective Therapeutics, Inc.	--
Protalix Biotherapeutics, Inc.	--
Electromed, Inc.	--
Armata Pharmaceuticals, Inc.	--